Dr. Ernesto Ayala, MD

Dr. Ayala practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Ayala's NPI, 1336164342, was assigned on July 12, 2006. Dr. Ayala graduated from National University of Colombia in 1985. Dr. Ayala holds Florida license ME91213.

Dr. Ayala's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Ayala's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. Dr. Ayala is also affiliated with AdventHealth Daytona Beach. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ayala practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ayala's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Ayala is board certified in hematology by the American Board of Internal Medicine. Dr. Ayala is licensed in Florida.

Dmand AI lists chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Ayala treats.

CMS data shows 89,822 Medicare services from Dr. Ayala across 60 procedure codes in 2024, for 850 Medicare patients. Medicare paid $1,385,138 for them.

CMS counts 850 Medicare patients who saw Dr. Ayala in 2024. The largest group is 65 to 74, with 414 patients. 72% of them have high blood pressure, and 72% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ayala's median patient age at 64, with 47% women.

In 2024, Dr. Ayala wrote 185 Medicare Part D claims for 33 patients. 83% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $155,975 in total drug cost. In 2023, CMS named 76 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ayala for performance year 2024, reported as part of a group. Dr. Ayala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ayala as offering telehealth.

Dmand AI links 120 papers to Dr. Ayala, published from 2006 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Graft vs Host Disease. Dr. Ayala has published most often in Bone Marrow Transplant. Dr. Ayala's most frequent co-authors are Claudio Anasetti, MD, Taiga Nishihori, MD and Lia E. Perez, MD.

Dmand AI links Dr. Ayala to 8 clinical trials, 3 of them phase 2 studies. Conditions studied include Bronchiolitis Obliterans Syndrome, Graft vs Host Disease and Immune System Diseases. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 6.

CMS Open Payments shows 15 general payments to Dr. Ayala from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Seagen Inc. paid the most, $486.

Dr. Ayala graduated from National University of Colombia in 1985. Dr. Ayala is a member of ASCO and ASH.

Dr. Ayala is in network with 6 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.